scispace - formally typeset
E

Emyr Lloyd-Evans

Researcher at Cardiff University

Publications -  63
Citations -  3632

Emyr Lloyd-Evans is an academic researcher from Cardiff University. The author has contributed to research in topics: Lysosomal storage disease & Biology. The author has an hindex of 22, co-authored 48 publications receiving 3159 citations. Previous affiliations of Emyr Lloyd-Evans include National Institutes of Health & University of Oxford.

Papers
More filters
PatentDOI

Substrate reduction therapy

TL;DR: In this article, an inhibitor of sphingolipid biosynthesis for use in the treatment of a disease which has a secondary Niemann-Pick type C disease like cellular phenotype was presented.
Journal ArticleDOI

Lysosomal Ca(2+) homeostasis: role in pathogenesis of lysosomal storage diseases.

TL;DR: A summary of the current knowledge on the role of lysosomal Ca(2+) signaling in the pathogenesis of LSDs is provided, finding that Chediak-Higashi Syndrome cells have been reported to have enhanced lysOSomal Ca (2+) uptake whilst the TRPML1 protein defective in mucolipidosis type IV is believed to function as a Ca( 2+) channel.
Journal ArticleDOI

Beneficial effects of substrate reduction therapy in a mouse model of GM1 gangliosidosis

TL;DR: Functional improvement was greatest with NB-DNJ treatment which may potentially be caused by novel anti-inflammatory properties of NB- DNJ, and the efficacy and tolerability of NB and NB-DGJ in the beta-galactosidase knockout mouse was compared.
Journal ArticleDOI

Unbiased Cell-based Screening in a Neuronal Cell Model of Batten Disease Highlights an Interaction between Ca2+ Homeostasis, Autophagy, and CLN3 Protein Function

TL;DR: An important role for the CLN3 protein in intracellular Ca2+ handling and in autophagic pathway flux is supported and a proof-of-concept is established for the application of drug screening to Batten disease research.
Journal ArticleDOI

Disorders of cholesterol metabolism and their unanticipated convergent mechanisms of disease.

TL;DR: A surprising finding is not only shedding light on details of cellular cholesterol homeostasis but also suggesting novel approaches to therapy.